Cerity Partners’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Cerity Partners’s Portfolio ORGS Stock Details ORGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,000	Closed	-$115K	–	739
2021 Q1	$115K	Hold	2,000	–	–	﹤0.01%	679
2020 Q4	$90K	Hold	2,000	–	–	﹤0.01%	630
2020 Q3	$101K	Hold	2,000	–	–	﹤0.01%	489
2020 Q2	$122K	Hold	2,000	–	–	0.01%	438
2020 Q1	$76K	Hold	2,000	–	–	﹤0.01%	432
2019 Q4	$93K	Hold	2,000	–	–	﹤0.01%	525
2019 Q3	$89K	Hold	2,000	–	–	0.01%	466
2019 Q2	$89K	Buy	+2,000	New	+$90.2K	0.01%	468

Other funds holding ORGS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Cerity Partners's ORGS Position: Q2 2021 in Review

Cerity Partners sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 2,000 shares — an estimated $115K sold.

Cerity Partners first reported a position in ORGS in Q2 2019 and held it in 8 quarters. The position peaked at $122K in Q2 2020. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

Cerity Partners reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Cerity Partners sold 2,000 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $115K.
Cerity Partners first reported a position in Orgenesis Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Cerity Partners's Orgenesis Inc. Common Stock position peaked at $122K in Q2 2020.
33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on Cerity Partners's 13F filing for Q2 2021, filed 11 Aug 2021.